ICU Medical Inc
NASDAQ:ICUI
ICU Medical Inc
Total Equity
ICU Medical Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
ICU Medical Inc
NASDAQ:ICUI
|
Total Equity
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
|
Figs Inc
NYSE:FIGS
|
Total Equity
$437.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Total Equity
$911.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Equity
$4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
17%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Equity
$1.1B
|
CAGR 3-Years
35%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Equity
$1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
ICU Medical Inc
Glance View
ICU Medical Inc. emerged as an intriguing player in the healthcare sector, focusing on a mission-critical niche within the industry—safety and efficiency in medical devices for infusion therapy, oncology, and critical care applications. Founded with an innovative spirit, the company carved out a reputation by addressing a key challenge in the medical field: preventing bloodstream infections and the exposure of healthcare professionals to hazardous substances. This focus led to the development of specialized devices such as needle-free connectors and closed system transfer devices, which are integral to minimizing contamination risks. These innovations not only improved patient outcomes but also enhanced the working conditions of medical professionals, underpinning ICU Medical’s growth trajectory. ICU Medical generates revenue by designing and manufacturing these life-saving devices, which are distributed across hospitals and healthcare facilities worldwide. The company's business model revolves around creating products that align with strict regulatory standards, ensuring both safety and superiority in healthcare settings. As they ventured into diverse product lines, such as infusion pumps and systems, the firm leveraged strategic acquisitions to expand market reach and technological capabilities. These initiatives underscored ICU Medical's commitment to operational synergy and product innovation, enabling the company to remain competitive and continue scaling its operations in a constantly evolving healthcare landscape. With a steady focus on both organic growth and strategic partnerships, ICU Medical remains a crucial player in the global health economy, dedicated to advancing patient care and the efficiency of healthcare delivery systems.
See Also
What is ICU Medical Inc's Total Equity?
Total Equity
2.1B
USD
Based on the financial report for Dec 31, 2025, ICU Medical Inc's Total Equity amounts to 2.1B USD.
What is ICU Medical Inc's Total Equity growth rate?
Total Equity CAGR 10Y
14%
Over the last year, the Total Equity growth was 8%. The average annual Total Equity growth rates for ICU Medical Inc have been 1% over the past three years , 7% over the past five years , and 14% over the past ten years .